Digestome therapeutics inc
WebNov 16, 2024 · Digestome Therapeutics: ClinicalTrials.gov Identifier: NCT05121831 Other Study ID Numbers: DGX-001-01 : First Posted: November 16, 2024 Key Record Dates: Last Update Posted: August 3, 2024 Last Verified: August 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No: Layout table for additional information ... WebFeb 23, 2024 · to work with Digestome Therapeutics to develop DGX-001 for Chinese patients in need of innovative therapies,” commented Xianbo Zhou, MD, PhD, Co-founder and CEO of Zhongze Therapeutics. “DGX-001 represents an exciting and promising opportunity to treat a wide range of patients suffering from CNS diseases.” About …
Digestome therapeutics inc
Did you know?
WebJun 1, 2024 · Digestome Therapeutics. Digestome Therapeutics was established by Remiges Ventures, based on the ground-breaking research of Dr. Kousaku Ohinata from Kyoto University. Food affects mood, so Dr. Ohinata was inspired to identify active pharmaceutical ingredients that had origins in proteins from food sources. His well … WebTherapeutics. Headquarters Regions Asia-Pacific (APAC) Founded Date 2024. Founders Alan Au. Operating Status Active. Last Funding Type Venture - Series Unknown. Company Type For Profit. GT Apeiron Therapeutics is a developer of innovative drugs utilizing artificial intelligence technology. The company develops breakthrough investigational ...
WebNov 19, 2024 · Digestome Therapeutics was founded in 2024, is a private biotech company developing first-in-class therapeutics focused on the discovery and development of a new class of drugs that could treat depression, … WebMar 8, 2024 · SAN FRANCISCO, March 8, 2024 /PRNewswire/ -- Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate …
WebDigestome Therapeutics is a private biotech company developing first-in-class therapeutics targeting a clinically proven mechanism, VNS (vagus nerve stimulation). VNS has been FDA approved in epilepsy and depression, and is in trials for other psychiatric, neurodegenerative and inflammatory diseases. However, the products are medical … Web2 days ago · In Feb 2024, Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate the central nervous system (CNS) via the gut-brain-axis, announced today the completion of an exclusive out-licensing agreement of DGX-001 in the greater China territory with Zhongze Therapeutics.
WebDIGESTOME THERAPEUTICS, INC in San Francisco, CA Company Info Company Information Sponsored Links Company Contacts KENNETH NICHOLAS HORNE Chief …
WebDigestome Therapeutics is a private biotech company developing first-in-class therapeutics targeting a clinically proven mechanism, VNS (vagus nerve stimulation). VNS has been FDA approved in epilepsy and depression, and is in trials for other psychiatric, neurodegenerative and inflammatory diseases. However, the products are medical … gym tehuacanWebPrior to joining Remiges Ventures, Taka run TK Venture Partners, Inc., which served as a consultant in charge of finance and investments for biotech and business groups including Remiges Ventures. For Remiges Ventures’ first fund, he has been on the board and Interim President of Digestome Therapeutics, Inc. and other newco projects in the ... gymtegrity summer campWebClients Zhongze Therapeutics (Cayman) Holding Limited. Jones Day represented Zhongze Therapeutics (Cayman) Holding, Ltd. in an exclusive license and collaboration agreement with Digestome Therapeutics, Inc. to develop, manufacture, and commercialize Digestome's first-in-class oral therapeutic ALT-100 in the Greater China territory. gym tehachapi caWebSenior Scientist at PTC Therapeutics, Inc. Kendall Park, New Jersey, United States. 316 followers 309 connections. Join to view profile PTC … gymtek academy knoxville tnWebFeb 27, 2024 · Information on valuation, funding, cap tables, investors, and executives for Digestome Therapeutics. Use the PitchBook Platform to explore the full profile. bp oil fineWebFeb 25, 2024 · SAN FRANCISCO, Feb. 25, 2024 /PRNewswire/ -- Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate … gym tech tredemølleWebFeb 25, 2024 · SAN FRANCISCO, Feb. 25, 2024 /PRNewswire/ -- Digestome Therapeutics, a biotech company developing first-in-class therapeutics that stimulate … gymtegrity gymnastics \\u0026 cheer